Targeting HER2 as a therapeutic strategy for breast cancer: A paradigmatic shift of drug development in oncology

M. De Laurentiis, G. Cancello, L. Zinno, E. Montagna, L. Malorni, A. Esposito, R. Pennacchio, L. Silvestro, M. Giuliano, A. Giordano, F. Caputo, A. Accurso, Sabino De Placido

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Targeting HER2 as a therapeutic strategy for breast cancer: A paradigmatic shift of drug development in oncology'. Together they form a unique fingerprint.

Medicine & Life Sciences